When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 29 Aug 2023

Summary

Definition

History and exam

Key diagnostic factors

  • history of known gene mutation
  • use of drugs or circumstances known to increase the QT interval
  • syncope during heightened adrenergic tones
  • syncope during arousal or surprise
  • arrhythmic symptoms postpartum
  • syncope at rest and during bradycardia
  • cardiac syncope
  • palpitations
  • periodic paralysis
  • dysmorphic features
  • sensorineural deafness

Other diagnostic factors

  • dizziness
  • angina
  • fatigue
  • oliguria
  • muscle weakness
  • tetany
  • numbness
  • Chvostek's sign
  • Trousseau's sign
  • cold and pale extremities
  • hypotension
  • confusion

Risk factors

  • KCNQ1 gene mutations
  • KCNH2 gene mutations
  • SCN5A gene mutations
  • QT interval-prolonging drugs
  • hypokalemia
  • hypomagnesemia
  • hypocalcemia
  • bradyarrhythmias
  • central nervous system lesions
  • female sex
  • malnutrition

Diagnostic tests

1st tests to order

  • ECG for LQT1
  • ECG for LQT2
  • ECG for LQT3
  • ECG for hypokalemia and hypomagnesemia
  • ECG for hypocalcemia
  • ECG for complete atrioventricular (AV) block
  • serum potassium
  • serum magnesium
  • serum calcium

Tests to consider

  • Holter monitor
  • exercise tolerance test
  • echocardiography
  • genetic testing
  • epinephrine test

Treatment algorithm

Contributors

Authors

Mehmet K. Aktas, MD, MBA

Associate Professor of Medicine

University of Rochester Medical Center

Rochester

NY

Disclosures

MKA declares that he has received research grants from Astra Zeneca, Medtronic, and Boston Scientific. MKA has served as consultant for Abbott and Huxley Medical. MKA holds a patent for "ECG Clock Electrocardiogram Based Diagnostic Device and Method" (US patent #10,085,667). He is the author of a reference cited in this topic.

James P. Daubert, MD

Professor of Medicine

Duke University Medical Center

Duke Clinical Research Institute

Durham

NC

Disclosures

JPD declares that he has received honoraria for advisory boards, steering committees, data safety monitoring boards, events committees, and lecture fees from Abbott, Acutus Medical, Affera Inc., Biosense Webster, Biotronik, Boston Scientific, Farapulse, Gilead Sciences Inc., Medtronic, Microport, Phillips, and Vytronus; and research grants from Abbott, Biosense Webster, Boston Scientific, Farapulse, and Medtronic. He receives royalty payments from Wiley, Springboard and McGraw Hill for textbook authorship and educational materials. JPD declares that he has no stock, stock options, or other forms of ownership. He is the author of a reference cited in this topic.

Peer reviewers

Sami Viskin, MD

Director of Cardiac Hospitalization

Department of Cardiology

Tel Aviv Medical Center

Tel Aviv

Israel

Disclosures

SV declares that he has no competing interests.

Elizabeth S. Kaufman, MD

Associate Professor

Heart and Vascular Center

MetroHealth Campus

Case Western Reserve University

Cleveland

OH

Disclosures

ESK declares that she has no competing interests.

Use of this content is subject to our disclaimer